Trial Profile
Teriparatide versus risedronic acid in men with glucocorticosteroid-induced osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Teriparatide
- Indications Male osteoporosis
- Focus Therapeutic Use
- Acronyms EuroGIOPS
- Sponsors Lilly Research Centre
- 11 Oct 2011 New trial record
- 20 Sep 2011 Results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.